FDA says bee pollen weight loss products pose health risks

June 20, 2014
FDA: bee pollen weight loss products pose health risks
Some contain undeclared ingredients that can harm people with high blood pressure, other ailments, agency says.

(HealthDay)—Some bee pollen products marketed for weight loss may actually threaten your health, the U.S. Food and Drug Administration warns.

These potentially dangerous products have been found to contain undeclared ingredients that may harm people who have conditions such as , irregular heartbeat and bipolar disorder, the agency said.

According to the FDA, the undeclared ingredients sibutramine and/or phenolphthalein have been found in the following bee pollen products: Zi Xiu Tang, Ultimate Formula, Fat Zero, Bella Vi Amp'd Up, Insane Amp'd Up, Slim Trim U, Infinity, Perfect Body Solution, Asset Extreme, Asset Extreme Plus, Asset Bold, and Asset Bee Pollen.

Sibutramine was removed from the U.S. market in late 2010 after studies showed that it increased people's risk of heart attack and stroke. Phenolphthalein, a laxative and a suspected cancer-causing agent, isn't approved in the United States, the FDA said.

The agency said it has received more than 50 reports of problems caused by tainted bee pollen weight loss products, including at least one death, serious heart issues, chest pain, heart palpitations, increased heart rate, elevated blood pressure, seizures, suicidal thoughts, anxiety, insomnia and diarrhea.

The FDA is testing other bee pollen weight loss products suspected to contain undeclared drugs.

The FDA also noted that many bee pollen products make unproven claims about treating or preventing a number of diseases and signs or symptoms of disease, including obesity, allergies, high blood pressure and cholesterol.

"When people buy these tainted bee pollen weight loss products, they are unknowingly taking one or more hidden drugs that have been banned from the market," Gary Coody, FDA's national health fraud coordinator, said in an agency news release.

Consumers and health care professionals should report any adverse events caused by bee pollen products to the FDA's MedWatch program at http://www..gov/Safety/MedWatch.

"It is tempting to believe that a quick and effortless weight loss supplement is safe for use," Jason Humbert, a senior regulatory manager with FDA's Office of Regulatory Affairs, said in the news release. "But given the fact that these products contain a hidden dangerous ingredient, consumers should avoid taking them."

Explore further: US warns of cancer-agent in Japan weight loss pills

More information: The U.S. National Institute of Diabetes and Digestive and Kidney Diseases explains how to choose a safe and successful weight loss program.

Related Stories

US warns of cancer-agent in Japan weight loss pills

April 3, 2012
The US Food and Drug Administration on Tuesday warned consumers not to take a product called "Japan Rapid Weight Loss Diet Pills" because they contain a suspected cancer-causing agent.

Bee pollen supplements can cause anaphylactic reactions

May 22, 2012
Although many people take bee pollen as a health supplement, it can cause severe anaphylactic reactions. However, most people are unaware of the risks, states an article published in CMAJ (Canadian Medical Association Journal).

Steer clear of 'miracle cures,' other bogus health products: FDA

March 6, 2013
(HealthDay)—Fraudulent health products are commonplace and can cause serious injury or even death, the U.S. Food and Drug Administration warns.

FDA approves generic version of celebrex

June 3, 2014
(HealthDay)—The U.S. Food and Drug Administration on Friday gave its approval to the first generic version of the pain reliever Celebrex (celecoxib).

US approves novel remedy for hayfever, pollen allergies (Update)

April 2, 2014
US regulators on Wednesday approved a French-made remedy for alleviating symptoms of hayfever and certain allergies to grass pollen.

Company recalls weight loss supplements

June 15, 2013
A South Florida company is voluntarily recalling weight loss supplements called "JaDera" and "Xiyouji Qingzhi."

Recommended for you

Patients receive most opioids at the doctor's office, not the ER

January 16, 2018
Around the country, state legislatures and hospitals have tightened emergency room prescribing guidelines for opioids to curb the addiction epidemic, but a new USC study shows that approach diverts attention from the main ...

FDA bans use of opioid-containing cough meds by kids

January 12, 2018
(HealthDay)—Trying to put a dent in the ongoing opioid addiction crisis, the U.S. Food and Drug Administration on Thursday slapped strict new restrictions on the use of opioid-containing cold and cough products by kids.

Taking ibuprofen for long periods found to alter human testicular physiology

January 9, 2018
A team of researchers from Denmark and France has found that taking regular doses of the pain reliever ibuprofen over a long period of time can lead to a disorder in men called compensated hypogonadism. In their paper published ...

Nearly one-third of Canadians have used opioids: study

January 9, 2018
Nearly one in three Canadians (29 percent) have used "some form of opioids" in the past five years, according to data released Tuesday as widespread fentanyl overdoses continue to kill.

Growing opioid epidemic forcing more children into foster care

January 8, 2018
The opioid epidemic has become so severe it's considered a national public health emergency. Addiction to prescription painkillers, such as oxycodone and morphine, has contributed to a dramatic rise in overdose deaths and ...

Price tag on gene therapy for rare form of blindness: $850K

January 3, 2018
A first-of-its kind genetic treatment for blindness will cost $850,000 per patient, making it one of the most expensive medicines in the world and raising questions about the affordability of a coming wave of similar gene-targeting ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.